NCT04564703 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04564703
Title	Iberdomide (Cc220) Maintenance After Asct in Newly Diagnosed MM Patients
Recruitment	Active, not recruiting
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	European Myeloma Network
Indications	multiple myeloma
Therapies	Iberdomide
Age Groups:	senior \| adult
Covered Countries	NLD \| ITA \| GRC \| FRA

Filter rows:

Showing 1 to 4 of 4 entries

Facility	City	Country	Details
Alexandra General Hospital -Department of Clinical Therapeutics N.K. Univ. of Athens	Athens	Greece	Details
CHU Hôtel-Dieu, 1, place Alexis Ricordeau, 44093 NANTES Cedex 1, FRANCE	Nantes	France	Details
Ospedale Generale Regionale-Divisione di Ematologia e Centro Trapianto Midollo Osseo	Bolzano	Italy	Details
Vrije Universiteit Medical Center (VUMC)	Amsterdam	Netherlands	Details

Showing 1 to 4 of 4 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT04564703Clinical Trial Detail